Fig. 4From: First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric studyPSA-values over the follow-up period of 12 months after TULSA. Developments of PSA values during a follow-up period of 12 months are visualized. PSA significantly decreased after TULSA.Back to article page